Air Pollution Accounts for Millions of Asthma ER Episodes
|
By HospiMedica International staff writers Posted on 26 Nov 2018 |

Image: Air pollution is a major contributor to global asthma burden, according to a new study (Photo courtesy of 123rf.com).
Ambient air pollution is major contributor to the global asthma burden, responsible for millions of emergency room (ER) visits, according to a new study.
Researchers at Dalhousie University (Halifax, NS, Canada), George Washington University (GW; Washington, DC, USA), the Stockholm Environment Institute (York, United Kingdom), and other institutions examined various national and regional ER visit rates, baseline asthma incidence and prevalence rates, and pollutant concentrations in order to estimate the number of asthma ER visits and new onset asthma cases globally that could be attributed to fine particulate matter (PM2.5), ozone, and nitrogen dioxide (NO2) concentrations.
The results showed that nine to 23 million annual asthma ER visits globally (8-20% of total global asthma ER visits) may be triggered by ozone, a pollutant generated when emissions from cars, power plants, and other combustion sources interact with sunlight; five to 10 million asthma ER visits (4-9% percent of total global asthma ER visits) were linked to PM2.5, small particles of pollutants that can lodge deep in the lung’s airways. The wide range of estimates reflects the application of central risk approximations from different epidemiological meta-analyses.
About half of the asthma ER visits attributed to dirty air were estimated to occur in South and East Asian countries, notably India and China. And although the air in the United States is relatively clean compared to South and East Asian countries, ozone and particulate matter were estimated to contribute 8-21% and 3-11% of asthma ER visits in the United States, respectively. The researchers suggest that countries like India and China may be harder hit by asthma burden because they have large populations and tend to have fewer restrictions on factories belching smoke and other sources of pollution.
Human-derived emissions were responsible for about 37% and 73% of ozone and PM2.5 asthma ER impacts, respectively. The remaining impacts were attributable to naturally occurring ozone precursor emissions, such as those from vegetation and lightning, and also due to PM2.5 factors such as dust and sea salt, although several of these sources are also influenced by humans. As reported, the largest ER impacts were found in China and India. The study was published on October 24, 2018, in Environmental Health Perspectives.
“We know that air pollution is the leading environmental health risk factor globally. Millions of people worldwide have to go to emergency rooms for asthma attacks every year because they are breathing dirty air,” said lead author Susan Anenberg, PhD, MSc, associate professor of environmental and occupational health at GW. “The range of global public health impacts from breathing dirty air is even more far reaching, and includes millions of asthma attacks every year. Policies aimed at cleaning up the air can reduce the global burden of asthma and improve respiratory health around the world.”
Asthma is the most prevalent chronic respiratory disease worldwide, affecting about 358 million people. It is characterized by variable, recurring symptoms, reversible airflow obstruction, and bronchospasm. Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath, which may occur a few times a day or a few times per week. Diagnosis is usually based on the pattern of symptoms, response to therapy over time and spirometry.
Related Links:
Dalhousie University
George Washington University
Stockholm Environment Institute
Researchers at Dalhousie University (Halifax, NS, Canada), George Washington University (GW; Washington, DC, USA), the Stockholm Environment Institute (York, United Kingdom), and other institutions examined various national and regional ER visit rates, baseline asthma incidence and prevalence rates, and pollutant concentrations in order to estimate the number of asthma ER visits and new onset asthma cases globally that could be attributed to fine particulate matter (PM2.5), ozone, and nitrogen dioxide (NO2) concentrations.
The results showed that nine to 23 million annual asthma ER visits globally (8-20% of total global asthma ER visits) may be triggered by ozone, a pollutant generated when emissions from cars, power plants, and other combustion sources interact with sunlight; five to 10 million asthma ER visits (4-9% percent of total global asthma ER visits) were linked to PM2.5, small particles of pollutants that can lodge deep in the lung’s airways. The wide range of estimates reflects the application of central risk approximations from different epidemiological meta-analyses.
About half of the asthma ER visits attributed to dirty air were estimated to occur in South and East Asian countries, notably India and China. And although the air in the United States is relatively clean compared to South and East Asian countries, ozone and particulate matter were estimated to contribute 8-21% and 3-11% of asthma ER visits in the United States, respectively. The researchers suggest that countries like India and China may be harder hit by asthma burden because they have large populations and tend to have fewer restrictions on factories belching smoke and other sources of pollution.
Human-derived emissions were responsible for about 37% and 73% of ozone and PM2.5 asthma ER impacts, respectively. The remaining impacts were attributable to naturally occurring ozone precursor emissions, such as those from vegetation and lightning, and also due to PM2.5 factors such as dust and sea salt, although several of these sources are also influenced by humans. As reported, the largest ER impacts were found in China and India. The study was published on October 24, 2018, in Environmental Health Perspectives.
“We know that air pollution is the leading environmental health risk factor globally. Millions of people worldwide have to go to emergency rooms for asthma attacks every year because they are breathing dirty air,” said lead author Susan Anenberg, PhD, MSc, associate professor of environmental and occupational health at GW. “The range of global public health impacts from breathing dirty air is even more far reaching, and includes millions of asthma attacks every year. Policies aimed at cleaning up the air can reduce the global burden of asthma and improve respiratory health around the world.”
Asthma is the most prevalent chronic respiratory disease worldwide, affecting about 358 million people. It is characterized by variable, recurring symptoms, reversible airflow obstruction, and bronchospasm. Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath, which may occur a few times a day or a few times per week. Diagnosis is usually based on the pattern of symptoms, response to therapy over time and spirometry.
Related Links:
Dalhousie University
George Washington University
Stockholm Environment Institute
Latest Critical Care News
- Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreSurgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







